Singaporean Pharmaceuticals & Biotech Most Popular Stocks

Haw Par

Market Cap: S$3.2b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

Hyphens Pharma International

Market Cap: S$115.8m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

iX Biopharma

Market Cap: S$32.0m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

Pharmesis International

Market Cap: S$14.4m

An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.